Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction
Open Access
- 20 August 1998
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (8) , 489-497
- https://doi.org/10.1056/nejm199808203390801
Abstract
Long-term administration of beta-adrenergic blockers to patients after myocardial infarction improves survival. However, physicians are reluctant to administer beta-blockers to many patients, such as older patients and those with chronic pulmonary disease, left ventricular dysfunction, or non–Q-wave myocardial infarction.Keywords
This publication has 37 references indexed in Scilit:
- Improving the Quality of Care for Medicare Patients With Acute Myocardial InfarctionJAMA, 1998
- Cardiologists' practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarctionJournal of the American College of Cardiology, 1995
- Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practiceJournal of the American College of Cardiology, 1995
- Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular ProjectPublished by American Medical Association (AMA) ,1995
- Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarctionPublished by American Medical Association (AMA) ,1988
- APACHE IICritical Care Medicine, 1985
- The beta-blocker heart attack trial. beta-Blocker Heart Attack Study GroupJAMA, 1981
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Treatment of myocardial infarction in a coronary care unitThe American Journal of Cardiology, 1967